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The Role of Uridine-Cytidine Kinase 2 in the Development of Hepatocellular Carcinoma 
Dehai Wu1, Tao Song1, 2, Keunsoo Ahn1, Nicha Wongjarupong1, Lewis R Roberts1 
1 Divison of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and 
Science, Rochester, MN, United States. 
2 Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi`an Jiaotong 
University, Xi`an, Shanxi, China 
Background and Objectives: Hepatocellular Carcinoma (HCC) is the most common 
primary malignancy of the liver and is the third most common cause of cancer-related 
death in the world. There are limited options for effective treatment of advanced HCC. 
We investigated the role of uridine-cytidine kinase 2 (UCK2) in the development of HCC 
and its potential as a target for treatment. 
Methods: Gene expression data from 377 patients in the TCGA HCC Project and 
protein expression data from 156 HCCs arrayed on tissue microarrays were analyzed 
for associations with survival and other clinical characteristics. In in vitro studies, we 
studied the functional consequences of forced expression of UCK2 in Huh7 and 
SNU387 cells, which have low endogenous expression of UCK2, and in Hep3B cells, 
which have high expression of UCK2. We also explored the mechanisms by which 
UCK2 promotes HCC tumorigenesis. 
Results: mRNA expression of UCK2 was associated with both overall survival and 
disease free survival of HCC patients, while protein expression was only associated 
with overall survival. In in vitro studies, overexpression of UCK2 promoted proliferation 
and migration of Huh7 and SNU387 cell lines, while knockdown of UCK2 suppressed 
the proliferation and migration of the Hep3B cell line. UCK2 activated an EGFR-AKT-
mTOR signaling axis at least in part through up-regulating the expression of EGFR. In 
turn, UCK2 was up-regulated by TGFβ1 through Smad2/Smad3 dependent 
demethylation. 
Conclusion: UCK2 enhances HCC tumorigenesis by mediating crosstalk between the 
TGFβ and EGFR signaling pathways. 
